Tocilizumab as first treatment option in optic neuropathy secondary to Graves’ orbitopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab as first treatment option in optic neuropathy secondary to Graves’ orbitopathy

Published:2018-02-08 Issue:6 Volume:37 Page:450-453
ISSN:0167-6830
Container-title:Orbit
language:en
Short-container-title:Orbit

Author:

Pascual-Camps I.¹^ORCID,Molina-Pallete R.¹,Bort-Martí M. A.¹,Todolí J.²,España-Gregori E.¹³

Affiliation:

1. Department of Ophthalmology, Hospital Universitario y Politécnico La Fe, Valencia, Spain

2. Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia, Spain

3. Department of Surgery, University of Valencia, Valencia, Spain

Publisher

Informa UK Limited

Subject

Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01676830.2018.1435694

Reference10 articles.

1. Optic Nerve Involvement in Dysthyroidism

2. Treatment of Active Corticosteroid-Resistant Graves’ Orbitopathy

3. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey

4. Acute Dysthyroid Optic Neuropathy Exacerbated by Orbital Radiotherapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficiency and Safety of Tocilizumab for the Treatment of Thyroid Eye Disease: A Systematic Review;Ophthalmic Plastic & Reconstructive Surgery;2024-01-12

2. Dysthyroid Optic Neuropathy;Ophthalmic Plastic & Reconstructive Surgery;2023-12

3. Dysthyroid optic neuropathy: emerging treatment strategies;Journal of Endocrinological Investigation;2023-02-18

4. A 46-Year-Old Woman with a 4-Year History of Graves Disease, with Severe Corticosteroid-Unresponsive Thyroid Eye Disease, Successfully Treated with Tocilizumab;American Journal of Case Reports;2023-01-20

5. Diagnosis and Management of Dysthyroid Optic Neuropathy;International Ophthalmology Clinics;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3